Global Severe Asthma Treatment Supply, Demand and Key Producers, 2023-2029
The global Severe Asthma Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Severe Asthma Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Severe Asthma Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Severe Asthma Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Severe Asthma Treatment total production and demand, 2018-2029, (K Units)
Global Severe Asthma Treatment total production value, 2018-2029, (USD Million)
Global Severe Asthma Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Severe Asthma Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Severe Asthma Treatment domestic production, consumption, key domestic manufacturers and share
Global Severe Asthma Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Severe Asthma Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Severe Asthma Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Severe Asthma Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma and Morphosys, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Severe Asthma Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Severe Asthma Treatment Market, By Region:
1. How big is the global Severe Asthma Treatment market?
2. What is the demand of the global Severe Asthma Treatment market?
3. What is the year over year growth of the global Severe Asthma Treatment market?
4. What is the production and production value of the global Severe Asthma Treatment market?
5. Who are the key producers in the global Severe Asthma Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Severe Asthma Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Severe Asthma Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Severe Asthma Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Severe Asthma Treatment total production and demand, 2018-2029, (K Units)
Global Severe Asthma Treatment total production value, 2018-2029, (USD Million)
Global Severe Asthma Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Severe Asthma Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Severe Asthma Treatment domestic production, consumption, key domestic manufacturers and share
Global Severe Asthma Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Severe Asthma Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Severe Asthma Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Severe Asthma Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma and Morphosys, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Severe Asthma Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Severe Asthma Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- lnhaled
- lntravenous
- Subcutaneous
- Children
- Adults
- Teenagers
- Teva Pharmaceutical
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Sanofi
- Regeneron Pharmaceutical
- 4D Pharma plc
- AB Pharma
- Morphosys
- Roche
- Avalo Therapeutics
- Suzhou Connect Biopharmaceuticals
- Pieris Pharma
- Biosion
1. How big is the global Severe Asthma Treatment market?
2. What is the demand of the global Severe Asthma Treatment market?
3. What is the year over year growth of the global Severe Asthma Treatment market?
4. What is the production and production value of the global Severe Asthma Treatment market?
5. Who are the key producers in the global Severe Asthma Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Severe Asthma Treatment Introduction
1.2 World Severe Asthma Treatment Supply & Forecast
1.2.1 World Severe Asthma Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Severe Asthma Treatment Production (2018-2029)
1.2.3 World Severe Asthma Treatment Pricing Trends (2018-2029)
1.3 World Severe Asthma Treatment Production by Region (Based on Production Site)
1.3.1 World Severe Asthma Treatment Production Value by Region (2018-2029)
1.3.2 World Severe Asthma Treatment Production by Region (2018-2029)
1.3.3 World Severe Asthma Treatment Average Price by Region (2018-2029)
1.3.4 North America Severe Asthma Treatment Production (2018-2029)
1.3.5 Europe Severe Asthma Treatment Production (2018-2029)
1.3.6 China Severe Asthma Treatment Production (2018-2029)
1.3.7 Japan Severe Asthma Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Severe Asthma Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Severe Asthma Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Severe Asthma Treatment Demand (2018-2029)
2.2 World Severe Asthma Treatment Consumption by Region
2.2.1 World Severe Asthma Treatment Consumption by Region (2018-2023)
2.2.2 World Severe Asthma Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Severe Asthma Treatment Consumption (2018-2029)
2.4 China Severe Asthma Treatment Consumption (2018-2029)
2.5 Europe Severe Asthma Treatment Consumption (2018-2029)
2.6 Japan Severe Asthma Treatment Consumption (2018-2029)
2.7 South Korea Severe Asthma Treatment Consumption (2018-2029)
2.8 ASEAN Severe Asthma Treatment Consumption (2018-2029)
2.9 India Severe Asthma Treatment Consumption (2018-2029)
3 WORLD SEVERE ASTHMA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Severe Asthma Treatment Production Value by Manufacturer (2018-2023)
3.2 World Severe Asthma Treatment Production by Manufacturer (2018-2023)
3.3 World Severe Asthma Treatment Average Price by Manufacturer (2018-2023)
3.4 Severe Asthma Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Severe Asthma Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Severe Asthma Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Severe Asthma Treatment in 2022
3.6 Severe Asthma Treatment Market: Overall Company Footprint Analysis
3.6.1 Severe Asthma Treatment Market: Region Footprint
3.6.2 Severe Asthma Treatment Market: Company Product Type Footprint
3.6.3 Severe Asthma Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Severe Asthma Treatment Production Value Comparison
4.1.1 United States VS China: Severe Asthma Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Severe Asthma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Severe Asthma Treatment Production Comparison
4.2.1 United States VS China: Severe Asthma Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Severe Asthma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Severe Asthma Treatment Consumption Comparison
4.3.1 United States VS China: Severe Asthma Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Severe Asthma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Severe Asthma Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Severe Asthma Treatment Production (2018-2023)
4.5 China Based Severe Asthma Treatment Manufacturers and Market Share
4.5.1 China Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Severe Asthma Treatment Production (2018-2023)
4.6 Rest of World Based Severe Asthma Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Severe Asthma Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Severe Asthma Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 lnhaled
5.2.3 lntravenous
5.2.4 Subcutaneous
5.3 Market Segment by Type
5.3.1 World Severe Asthma Treatment Production by Type (2018-2029)
5.3.2 World Severe Asthma Treatment Production Value by Type (2018-2029)
5.3.3 World Severe Asthma Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Severe Asthma Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Children
6.2.2 Adults
6.2.3 Teenagers
6.3 Market Segment by Application
6.3.1 World Severe Asthma Treatment Production by Application (2018-2029)
6.3.2 World Severe Asthma Treatment Production Value by Application (2018-2029)
6.3.3 World Severe Asthma Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Details
7.1.2 Teva Pharmaceutical Major Business
7.1.3 Teva Pharmaceutical Severe Asthma Treatment Product and Services
7.1.4 Teva Pharmaceutical Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceutical Recent Developments/Updates
7.1.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Severe Asthma Treatment Product and Services
7.2.4 AstraZeneca Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Details
7.3.2 GlaxoSmithKline Major Business
7.3.3 GlaxoSmithKline Severe Asthma Treatment Product and Services
7.3.4 GlaxoSmithKline Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GlaxoSmithKline Recent Developments/Updates
7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Severe Asthma Treatment Product and Services
7.4.4 Novartis Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Severe Asthma Treatment Product and Services
7.5.4 Sanofi Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Regeneron Pharmaceutical
7.6.1 Regeneron Pharmaceutical Details
7.6.2 Regeneron Pharmaceutical Major Business
7.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Product and Services
7.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Regeneron Pharmaceutical Recent Developments/Updates
7.6.6 Regeneron Pharmaceutical Competitive Strengths & Weaknesses
7.7 4D Pharma plc
7.7.1 4D Pharma plc Details
7.7.2 4D Pharma plc Major Business
7.7.3 4D Pharma plc Severe Asthma Treatment Product and Services
7.7.4 4D Pharma plc Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 4D Pharma plc Recent Developments/Updates
7.7.6 4D Pharma plc Competitive Strengths & Weaknesses
7.8 AB Pharma
7.8.1 AB Pharma Details
7.8.2 AB Pharma Major Business
7.8.3 AB Pharma Severe Asthma Treatment Product and Services
7.8.4 AB Pharma Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AB Pharma Recent Developments/Updates
7.8.6 AB Pharma Competitive Strengths & Weaknesses
7.9 Morphosys
7.9.1 Morphosys Details
7.9.2 Morphosys Major Business
7.9.3 Morphosys Severe Asthma Treatment Product and Services
7.9.4 Morphosys Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Morphosys Recent Developments/Updates
7.9.6 Morphosys Competitive Strengths & Weaknesses
7.10 Roche
7.10.1 Roche Details
7.10.2 Roche Major Business
7.10.3 Roche Severe Asthma Treatment Product and Services
7.10.4 Roche Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Roche Recent Developments/Updates
7.10.6 Roche Competitive Strengths & Weaknesses
7.11 Avalo Therapeutics
7.11.1 Avalo Therapeutics Details
7.11.2 Avalo Therapeutics Major Business
7.11.3 Avalo Therapeutics Severe Asthma Treatment Product and Services
7.11.4 Avalo Therapeutics Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Avalo Therapeutics Recent Developments/Updates
7.11.6 Avalo Therapeutics Competitive Strengths & Weaknesses
7.12 Suzhou Connect Biopharmaceuticals
7.12.1 Suzhou Connect Biopharmaceuticals Details
7.12.2 Suzhou Connect Biopharmaceuticals Major Business
7.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services
7.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Suzhou Connect Biopharmaceuticals Recent Developments/Updates
7.12.6 Suzhou Connect Biopharmaceuticals Competitive Strengths & Weaknesses
7.13 Pieris Pharma
7.13.1 Pieris Pharma Details
7.13.2 Pieris Pharma Major Business
7.13.3 Pieris Pharma Severe Asthma Treatment Product and Services
7.13.4 Pieris Pharma Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Pieris Pharma Recent Developments/Updates
7.13.6 Pieris Pharma Competitive Strengths & Weaknesses
7.14 Biosion
7.14.1 Biosion Details
7.14.2 Biosion Major Business
7.14.3 Biosion Severe Asthma Treatment Product and Services
7.14.4 Biosion Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Biosion Recent Developments/Updates
7.14.6 Biosion Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Severe Asthma Treatment Industry Chain
8.2 Severe Asthma Treatment Upstream Analysis
8.2.1 Severe Asthma Treatment Core Raw Materials
8.2.2 Main Manufacturers of Severe Asthma Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Severe Asthma Treatment Production Mode
8.6 Severe Asthma Treatment Procurement Model
8.7 Severe Asthma Treatment Industry Sales Model and Sales Channels
8.7.1 Severe Asthma Treatment Sales Model
8.7.2 Severe Asthma Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Severe Asthma Treatment Introduction
1.2 World Severe Asthma Treatment Supply & Forecast
1.2.1 World Severe Asthma Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Severe Asthma Treatment Production (2018-2029)
1.2.3 World Severe Asthma Treatment Pricing Trends (2018-2029)
1.3 World Severe Asthma Treatment Production by Region (Based on Production Site)
1.3.1 World Severe Asthma Treatment Production Value by Region (2018-2029)
1.3.2 World Severe Asthma Treatment Production by Region (2018-2029)
1.3.3 World Severe Asthma Treatment Average Price by Region (2018-2029)
1.3.4 North America Severe Asthma Treatment Production (2018-2029)
1.3.5 Europe Severe Asthma Treatment Production (2018-2029)
1.3.6 China Severe Asthma Treatment Production (2018-2029)
1.3.7 Japan Severe Asthma Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Severe Asthma Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Severe Asthma Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Severe Asthma Treatment Demand (2018-2029)
2.2 World Severe Asthma Treatment Consumption by Region
2.2.1 World Severe Asthma Treatment Consumption by Region (2018-2023)
2.2.2 World Severe Asthma Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Severe Asthma Treatment Consumption (2018-2029)
2.4 China Severe Asthma Treatment Consumption (2018-2029)
2.5 Europe Severe Asthma Treatment Consumption (2018-2029)
2.6 Japan Severe Asthma Treatment Consumption (2018-2029)
2.7 South Korea Severe Asthma Treatment Consumption (2018-2029)
2.8 ASEAN Severe Asthma Treatment Consumption (2018-2029)
2.9 India Severe Asthma Treatment Consumption (2018-2029)
3 WORLD SEVERE ASTHMA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Severe Asthma Treatment Production Value by Manufacturer (2018-2023)
3.2 World Severe Asthma Treatment Production by Manufacturer (2018-2023)
3.3 World Severe Asthma Treatment Average Price by Manufacturer (2018-2023)
3.4 Severe Asthma Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Severe Asthma Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Severe Asthma Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Severe Asthma Treatment in 2022
3.6 Severe Asthma Treatment Market: Overall Company Footprint Analysis
3.6.1 Severe Asthma Treatment Market: Region Footprint
3.6.2 Severe Asthma Treatment Market: Company Product Type Footprint
3.6.3 Severe Asthma Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Severe Asthma Treatment Production Value Comparison
4.1.1 United States VS China: Severe Asthma Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Severe Asthma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Severe Asthma Treatment Production Comparison
4.2.1 United States VS China: Severe Asthma Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Severe Asthma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Severe Asthma Treatment Consumption Comparison
4.3.1 United States VS China: Severe Asthma Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Severe Asthma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Severe Asthma Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Severe Asthma Treatment Production (2018-2023)
4.5 China Based Severe Asthma Treatment Manufacturers and Market Share
4.5.1 China Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Severe Asthma Treatment Production (2018-2023)
4.6 Rest of World Based Severe Asthma Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Severe Asthma Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Severe Asthma Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Severe Asthma Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 lnhaled
5.2.3 lntravenous
5.2.4 Subcutaneous
5.3 Market Segment by Type
5.3.1 World Severe Asthma Treatment Production by Type (2018-2029)
5.3.2 World Severe Asthma Treatment Production Value by Type (2018-2029)
5.3.3 World Severe Asthma Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Severe Asthma Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Children
6.2.2 Adults
6.2.3 Teenagers
6.3 Market Segment by Application
6.3.1 World Severe Asthma Treatment Production by Application (2018-2029)
6.3.2 World Severe Asthma Treatment Production Value by Application (2018-2029)
6.3.3 World Severe Asthma Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Details
7.1.2 Teva Pharmaceutical Major Business
7.1.3 Teva Pharmaceutical Severe Asthma Treatment Product and Services
7.1.4 Teva Pharmaceutical Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Pharmaceutical Recent Developments/Updates
7.1.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Severe Asthma Treatment Product and Services
7.2.4 AstraZeneca Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Details
7.3.2 GlaxoSmithKline Major Business
7.3.3 GlaxoSmithKline Severe Asthma Treatment Product and Services
7.3.4 GlaxoSmithKline Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GlaxoSmithKline Recent Developments/Updates
7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Severe Asthma Treatment Product and Services
7.4.4 Novartis Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Severe Asthma Treatment Product and Services
7.5.4 Sanofi Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Regeneron Pharmaceutical
7.6.1 Regeneron Pharmaceutical Details
7.6.2 Regeneron Pharmaceutical Major Business
7.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Product and Services
7.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Regeneron Pharmaceutical Recent Developments/Updates
7.6.6 Regeneron Pharmaceutical Competitive Strengths & Weaknesses
7.7 4D Pharma plc
7.7.1 4D Pharma plc Details
7.7.2 4D Pharma plc Major Business
7.7.3 4D Pharma plc Severe Asthma Treatment Product and Services
7.7.4 4D Pharma plc Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 4D Pharma plc Recent Developments/Updates
7.7.6 4D Pharma plc Competitive Strengths & Weaknesses
7.8 AB Pharma
7.8.1 AB Pharma Details
7.8.2 AB Pharma Major Business
7.8.3 AB Pharma Severe Asthma Treatment Product and Services
7.8.4 AB Pharma Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AB Pharma Recent Developments/Updates
7.8.6 AB Pharma Competitive Strengths & Weaknesses
7.9 Morphosys
7.9.1 Morphosys Details
7.9.2 Morphosys Major Business
7.9.3 Morphosys Severe Asthma Treatment Product and Services
7.9.4 Morphosys Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Morphosys Recent Developments/Updates
7.9.6 Morphosys Competitive Strengths & Weaknesses
7.10 Roche
7.10.1 Roche Details
7.10.2 Roche Major Business
7.10.3 Roche Severe Asthma Treatment Product and Services
7.10.4 Roche Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Roche Recent Developments/Updates
7.10.6 Roche Competitive Strengths & Weaknesses
7.11 Avalo Therapeutics
7.11.1 Avalo Therapeutics Details
7.11.2 Avalo Therapeutics Major Business
7.11.3 Avalo Therapeutics Severe Asthma Treatment Product and Services
7.11.4 Avalo Therapeutics Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Avalo Therapeutics Recent Developments/Updates
7.11.6 Avalo Therapeutics Competitive Strengths & Weaknesses
7.12 Suzhou Connect Biopharmaceuticals
7.12.1 Suzhou Connect Biopharmaceuticals Details
7.12.2 Suzhou Connect Biopharmaceuticals Major Business
7.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services
7.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Suzhou Connect Biopharmaceuticals Recent Developments/Updates
7.12.6 Suzhou Connect Biopharmaceuticals Competitive Strengths & Weaknesses
7.13 Pieris Pharma
7.13.1 Pieris Pharma Details
7.13.2 Pieris Pharma Major Business
7.13.3 Pieris Pharma Severe Asthma Treatment Product and Services
7.13.4 Pieris Pharma Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Pieris Pharma Recent Developments/Updates
7.13.6 Pieris Pharma Competitive Strengths & Weaknesses
7.14 Biosion
7.14.1 Biosion Details
7.14.2 Biosion Major Business
7.14.3 Biosion Severe Asthma Treatment Product and Services
7.14.4 Biosion Severe Asthma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Biosion Recent Developments/Updates
7.14.6 Biosion Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Severe Asthma Treatment Industry Chain
8.2 Severe Asthma Treatment Upstream Analysis
8.2.1 Severe Asthma Treatment Core Raw Materials
8.2.2 Main Manufacturers of Severe Asthma Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Severe Asthma Treatment Production Mode
8.6 Severe Asthma Treatment Procurement Model
8.7 Severe Asthma Treatment Industry Sales Model and Sales Channels
8.7.1 Severe Asthma Treatment Sales Model
8.7.2 Severe Asthma Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Severe Asthma Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Severe Asthma Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Severe Asthma Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Severe Asthma Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Severe Asthma Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Severe Asthma Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Severe Asthma Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Severe Asthma Treatment Production Market Share by Region (2018-2023)
Table 9. World Severe Asthma Treatment Production Market Share by Region (2024-2029)
Table 10. World Severe Asthma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Severe Asthma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Severe Asthma Treatment Major Market Trends
Table 13. World Severe Asthma Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Severe Asthma Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Severe Asthma Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Severe Asthma Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Severe Asthma Treatment Producers in 2022
Table 18. World Severe Asthma Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Severe Asthma Treatment Producers in 2022
Table 20. World Severe Asthma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Severe Asthma Treatment Company Evaluation Quadrant
Table 22. World Severe Asthma Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Severe Asthma Treatment Production Site of Key Manufacturer
Table 24. Severe Asthma Treatment Market: Company Product Type Footprint
Table 25. Severe Asthma Treatment Market: Company Product Application Footprint
Table 26. Severe Asthma Treatment Competitive Factors
Table 27. Severe Asthma Treatment New Entrant and Capacity Expansion Plans
Table 28. Severe Asthma Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Severe Asthma Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Severe Asthma Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Severe Asthma Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 37. China Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 47. World Severe Asthma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Severe Asthma Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Severe Asthma Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Severe Asthma Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Severe Asthma Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Severe Asthma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Severe Asthma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Severe Asthma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Severe Asthma Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Severe Asthma Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Severe Asthma Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Severe Asthma Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Severe Asthma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Severe Asthma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Major Business
Table 63. Teva Pharmaceutical Severe Asthma Treatment Product and Services
Table 64. Teva Pharmaceutical Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceutical Recent Developments/Updates
Table 66. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Severe Asthma Treatment Product and Services
Table 70. AstraZeneca Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline Major Business
Table 75. GlaxoSmithKline Severe Asthma Treatment Product and Services
Table 76. GlaxoSmithKline Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Severe Asthma Treatment Product and Services
Table 82. Novartis Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Severe Asthma Treatment Product and Services
Table 88. Sanofi Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Regeneron Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Pharmaceutical Major Business
Table 93. Regeneron Pharmaceutical Severe Asthma Treatment Product and Services
Table 94. Regeneron Pharmaceutical Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Regeneron Pharmaceutical Recent Developments/Updates
Table 96. Regeneron Pharmaceutical Competitive Strengths & Weaknesses
Table 97. 4D Pharma plc Basic Information, Manufacturing Base and Competitors
Table 98. 4D Pharma plc Major Business
Table 99. 4D Pharma plc Severe Asthma Treatment Product and Services
Table 100. 4D Pharma plc Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. 4D Pharma plc Recent Developments/Updates
Table 102. 4D Pharma plc Competitive Strengths & Weaknesses
Table 103. AB Pharma Basic Information, Manufacturing Base and Competitors
Table 104. AB Pharma Major Business
Table 105. AB Pharma Severe Asthma Treatment Product and Services
Table 106. AB Pharma Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AB Pharma Recent Developments/Updates
Table 108. AB Pharma Competitive Strengths & Weaknesses
Table 109. Morphosys Basic Information, Manufacturing Base and Competitors
Table 110. Morphosys Major Business
Table 111. Morphosys Severe Asthma Treatment Product and Services
Table 112. Morphosys Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Morphosys Recent Developments/Updates
Table 114. Morphosys Competitive Strengths & Weaknesses
Table 115. Roche Basic Information, Manufacturing Base and Competitors
Table 116. Roche Major Business
Table 117. Roche Severe Asthma Treatment Product and Services
Table 118. Roche Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Roche Recent Developments/Updates
Table 120. Roche Competitive Strengths & Weaknesses
Table 121. Avalo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Avalo Therapeutics Major Business
Table 123. Avalo Therapeutics Severe Asthma Treatment Product and Services
Table 124. Avalo Therapeutics Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Avalo Therapeutics Recent Developments/Updates
Table 126. Avalo Therapeutics Competitive Strengths & Weaknesses
Table 127. Suzhou Connect Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Suzhou Connect Biopharmaceuticals Major Business
Table 129. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services
Table 130. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Suzhou Connect Biopharmaceuticals Recent Developments/Updates
Table 132. Suzhou Connect Biopharmaceuticals Competitive Strengths & Weaknesses
Table 133. Pieris Pharma Basic Information, Manufacturing Base and Competitors
Table 134. Pieris Pharma Major Business
Table 135. Pieris Pharma Severe Asthma Treatment Product and Services
Table 136. Pieris Pharma Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Pieris Pharma Recent Developments/Updates
Table 138. Biosion Basic Information, Manufacturing Base and Competitors
Table 139. Biosion Major Business
Table 140. Biosion Severe Asthma Treatment Product and Services
Table 141. Biosion Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Severe Asthma Treatment Upstream (Raw Materials)
Table 143. Severe Asthma Treatment Typical Customers
Table 144. Severe Asthma Treatment Typical Distributors
Table 1. World Severe Asthma Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Severe Asthma Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Severe Asthma Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Severe Asthma Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Severe Asthma Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Severe Asthma Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Severe Asthma Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Severe Asthma Treatment Production Market Share by Region (2018-2023)
Table 9. World Severe Asthma Treatment Production Market Share by Region (2024-2029)
Table 10. World Severe Asthma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Severe Asthma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Severe Asthma Treatment Major Market Trends
Table 13. World Severe Asthma Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Severe Asthma Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Severe Asthma Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Severe Asthma Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Severe Asthma Treatment Producers in 2022
Table 18. World Severe Asthma Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Severe Asthma Treatment Producers in 2022
Table 20. World Severe Asthma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Severe Asthma Treatment Company Evaluation Quadrant
Table 22. World Severe Asthma Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Severe Asthma Treatment Production Site of Key Manufacturer
Table 24. Severe Asthma Treatment Market: Company Product Type Footprint
Table 25. Severe Asthma Treatment Market: Company Product Application Footprint
Table 26. Severe Asthma Treatment Competitive Factors
Table 27. Severe Asthma Treatment New Entrant and Capacity Expansion Plans
Table 28. Severe Asthma Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Severe Asthma Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Severe Asthma Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Severe Asthma Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 37. China Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Severe Asthma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Severe Asthma Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Severe Asthma Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Severe Asthma Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Severe Asthma Treatment Production Market Share (2018-2023)
Table 47. World Severe Asthma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Severe Asthma Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Severe Asthma Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Severe Asthma Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Severe Asthma Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Severe Asthma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Severe Asthma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Severe Asthma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Severe Asthma Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Severe Asthma Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Severe Asthma Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Severe Asthma Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Severe Asthma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Severe Asthma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Teva Pharmaceutical Major Business
Table 63. Teva Pharmaceutical Severe Asthma Treatment Product and Services
Table 64. Teva Pharmaceutical Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Pharmaceutical Recent Developments/Updates
Table 66. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Severe Asthma Treatment Product and Services
Table 70. AstraZeneca Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline Major Business
Table 75. GlaxoSmithKline Severe Asthma Treatment Product and Services
Table 76. GlaxoSmithKline Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Severe Asthma Treatment Product and Services
Table 82. Novartis Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Severe Asthma Treatment Product and Services
Table 88. Sanofi Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Regeneron Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Pharmaceutical Major Business
Table 93. Regeneron Pharmaceutical Severe Asthma Treatment Product and Services
Table 94. Regeneron Pharmaceutical Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Regeneron Pharmaceutical Recent Developments/Updates
Table 96. Regeneron Pharmaceutical Competitive Strengths & Weaknesses
Table 97. 4D Pharma plc Basic Information, Manufacturing Base and Competitors
Table 98. 4D Pharma plc Major Business
Table 99. 4D Pharma plc Severe Asthma Treatment Product and Services
Table 100. 4D Pharma plc Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. 4D Pharma plc Recent Developments/Updates
Table 102. 4D Pharma plc Competitive Strengths & Weaknesses
Table 103. AB Pharma Basic Information, Manufacturing Base and Competitors
Table 104. AB Pharma Major Business
Table 105. AB Pharma Severe Asthma Treatment Product and Services
Table 106. AB Pharma Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AB Pharma Recent Developments/Updates
Table 108. AB Pharma Competitive Strengths & Weaknesses
Table 109. Morphosys Basic Information, Manufacturing Base and Competitors
Table 110. Morphosys Major Business
Table 111. Morphosys Severe Asthma Treatment Product and Services
Table 112. Morphosys Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Morphosys Recent Developments/Updates
Table 114. Morphosys Competitive Strengths & Weaknesses
Table 115. Roche Basic Information, Manufacturing Base and Competitors
Table 116. Roche Major Business
Table 117. Roche Severe Asthma Treatment Product and Services
Table 118. Roche Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Roche Recent Developments/Updates
Table 120. Roche Competitive Strengths & Weaknesses
Table 121. Avalo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Avalo Therapeutics Major Business
Table 123. Avalo Therapeutics Severe Asthma Treatment Product and Services
Table 124. Avalo Therapeutics Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Avalo Therapeutics Recent Developments/Updates
Table 126. Avalo Therapeutics Competitive Strengths & Weaknesses
Table 127. Suzhou Connect Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Suzhou Connect Biopharmaceuticals Major Business
Table 129. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services
Table 130. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Suzhou Connect Biopharmaceuticals Recent Developments/Updates
Table 132. Suzhou Connect Biopharmaceuticals Competitive Strengths & Weaknesses
Table 133. Pieris Pharma Basic Information, Manufacturing Base and Competitors
Table 134. Pieris Pharma Major Business
Table 135. Pieris Pharma Severe Asthma Treatment Product and Services
Table 136. Pieris Pharma Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Pieris Pharma Recent Developments/Updates
Table 138. Biosion Basic Information, Manufacturing Base and Competitors
Table 139. Biosion Major Business
Table 140. Biosion Severe Asthma Treatment Product and Services
Table 141. Biosion Severe Asthma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Severe Asthma Treatment Upstream (Raw Materials)
Table 143. Severe Asthma Treatment Typical Customers
Table 144. Severe Asthma Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Severe Asthma Treatment Picture
Figure 2. World Severe Asthma Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Severe Asthma Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 5. World Severe Asthma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Severe Asthma Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Severe Asthma Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 10. China Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 12. Severe Asthma Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Severe Asthma Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Severe Asthma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Severe Asthma Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Severe Asthma Treatment Markets in 2022
Figure 26. United States VS China: Severe Asthma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Severe Asthma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Severe Asthma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 32. World Severe Asthma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Severe Asthma Treatment Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. lnhaled
Figure 36. lntravenous
Figure 37. Subcutaneous
Figure 38. World Severe Asthma Treatment Production Market Share by Type (2018-2029)
Figure 39. World Severe Asthma Treatment Production Value Market Share by Type (2018-2029)
Figure 40. World Severe Asthma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Severe Asthma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Severe Asthma Treatment Production Value Market Share by Application in 2022
Figure 43. Children
Figure 44. Adults
Figure 45. Teenagers
Figure 46. World Severe Asthma Treatment Production Market Share by Application (2018-2029)
Figure 47. World Severe Asthma Treatment Production Value Market Share by Application (2018-2029)
Figure 48. World Severe Asthma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Severe Asthma Treatment Industry Chain
Figure 50. Severe Asthma Treatment Procurement Model
Figure 51. Severe Asthma Treatment Sales Model
Figure 52. Severe Asthma Treatment Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Severe Asthma Treatment Picture
Figure 2. World Severe Asthma Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Severe Asthma Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 5. World Severe Asthma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Severe Asthma Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Severe Asthma Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 10. China Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Severe Asthma Treatment Production (2018-2029) & (K Units)
Figure 12. Severe Asthma Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Severe Asthma Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Severe Asthma Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Severe Asthma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Severe Asthma Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Severe Asthma Treatment Markets in 2022
Figure 26. United States VS China: Severe Asthma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Severe Asthma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Severe Asthma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Severe Asthma Treatment Production Market Share 2022
Figure 32. World Severe Asthma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Severe Asthma Treatment Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. lnhaled
Figure 36. lntravenous
Figure 37. Subcutaneous
Figure 38. World Severe Asthma Treatment Production Market Share by Type (2018-2029)
Figure 39. World Severe Asthma Treatment Production Value Market Share by Type (2018-2029)
Figure 40. World Severe Asthma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Severe Asthma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Severe Asthma Treatment Production Value Market Share by Application in 2022
Figure 43. Children
Figure 44. Adults
Figure 45. Teenagers
Figure 46. World Severe Asthma Treatment Production Market Share by Application (2018-2029)
Figure 47. World Severe Asthma Treatment Production Value Market Share by Application (2018-2029)
Figure 48. World Severe Asthma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Severe Asthma Treatment Industry Chain
Figure 50. Severe Asthma Treatment Procurement Model
Figure 51. Severe Asthma Treatment Sales Model
Figure 52. Severe Asthma Treatment Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
